Last-line drug resistance poses 'alarming' European health threat

November 17, 2014 10:17 AM

3 0

LONDON (Reuters) - More and more infections in Europe are proving able to evade even the most powerful, last-resort antibiotics, posing an alarming threat to patient safety in the region, health officials said on Monday.

Releasing annual data on antibiotic resistant superbugs, the European Center for Disease Prevention and Control (ECDC) said bacterial infections resistant to carbapenems -- a major last-line class of antibiotics used to treat hospital-acquired superbugs -- are ever more common in the European Union.

Also read: Intel reports better-than-expected earnings as data center chips grow 13% to $4.5 billion

Read more

To category page